{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:01:32Z","timestamp":1774861292627,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["122S951"],"award-info":[{"award-number":["122S951"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejso.2024.108783","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T12:52:38Z","timestamp":1729774358000},"page":"108783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the protein signature of endometrial cancer: A comprehensive review through diverse samples and mass spectrometry-based proteomics"],"prefix":"10.1016","volume":"51","author":[{"given":"Oyku Su","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-9987","authenticated-orcid":false,"given":"Pelin","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-6211","authenticated-orcid":false,"given":"Abdullah","family":"Karaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-0297","authenticated-orcid":false,"given":"Jean","family":"Calleja-Agius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-3696","authenticated-orcid":false,"given":"Sureyya","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.108783_bib1","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: national cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2024.108783_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.108783_bib3","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.108783_bib4","doi-asserted-by":"crossref","first-page":"9274","DOI":"10.3390\/ijms22179274","article-title":"Molecular basis of endometriosis and endometrial cancer: current knowledge and future perspectives","volume":"22","author":"Terzic","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2024.108783_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108783_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108783_bib7","first-page":"1851","article-title":"Factors associated with Type I and Type II endometrial cancer","volume":"21","author":"Felix","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejso.2024.108783_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humpath.2004.02.007","article-title":"Prognostic parameters of endometrial carcinoma","volume":"35","author":"Prat","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2024.108783_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/1055-9965.EPI-07-2567","article-title":"Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype","volume":"17","author":"McCullough","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejso.2024.108783_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PGP.0000000000000585","article-title":"Molecular classification and emerging targeted therapy in endometrial cancer","volume":"39","author":"Yen","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejso.2024.108783_bib11","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3390\/cancers15072053","article-title":"Determination of the Cancer Genome Atlas (TCGA) endometrial cancer molecular subtypes using the variant interpretation and clinical decision support software MH guide","volume":"15","author":"Mustea","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108783_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2024.108783_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5603\/GP.a2017.0062","article-title":"Biological markers with potential clinical value in endometrial cancer\u2014review of the literature","volume":"88","author":"Taoussi","year":"2017","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.ejso.2024.108783_bib14","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer: an umbrella review of the literature","volume":"145","author":"Raglan","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2024.108783_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.trac.2009.11.007","article-title":"Biomarker discovery and clinical proteomics","volume":"29","author":"Silberring","year":"2010","journal-title":"TrAC, Trends Anal Chem"},{"key":"10.1016\/j.ejso.2024.108783_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-0716-1024-4_8","article-title":"Quantitative mass spectrometry-based proteomics: an overview","author":"Rozanova","year":"2021","journal-title":"Quant Methods Proteomics"},{"key":"10.1016\/j.ejso.2024.108783_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","article-title":"The emerging role of mass spectrometry-based proteomics in drug discovery","volume":"21","author":"Meissner","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejso.2024.108783_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201900029","article-title":"Targeted and untargeted proteomics approaches in biomarker development","volume":"20","author":"Sobsey","year":"2020","journal-title":"Proteomics"},{"key":"10.1016\/j.ejso.2024.108783_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cbpa.2008.07.024","article-title":"Mass spectrometry for proteomics","volume":"12","author":"Han","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ejso.2024.108783_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-017-00249-5","article-title":"Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry","volume":"8","author":"Collins","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejso.2024.108783_bib21","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1021\/acs.jproteome.2c00121","article-title":"Optimization of ultrafast proteomics using an LC-quadrupole-orbitrap mass spectrometer with data-independent acquisition","volume":"21","author":"Ishikawa","year":"2022","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ejso.2024.108783_bib22","doi-asserted-by":"crossref","first-page":"e8126","DOI":"10.15252\/msb.20178126","article-title":"Data\u2010independent acquisition\u2010based SWATH\u2010MS for quantitative proteomics: a tutorial","volume":"14","author":"Ludwig","year":"2018","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.ejso.2024.108783_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nmeth.f.329","article-title":"Targeted proteomics","volume":"8","author":"Doerr","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.ejso.2024.108783_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/acs.analchem.7b04733","article-title":"Mass spectrometry imaging: a review of emerging advancements and future insights","volume":"90","author":"Buchberger","year":"2018","journal-title":"Anal Chem"},{"key":"10.1016\/j.ejso.2024.108783_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/s12885-024-12522-0","article-title":"Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer","volume":"24","author":"Akkour","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.108783_bib26","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1021\/acsomega.3c07992","article-title":"Plasma proteomic signature of endometrial cancer in patients with diabetes","volume":"9","author":"Mujammami","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejso.2024.108783_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914528","article-title":"Serum proteomic profiles of patients with high and low risk of endometrial cancer recurrence","volume":"24","author":"Pietkiewicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2024.108783_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajog.2019.06.005","article-title":"Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial","volume":"221","author":"Tarney","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejso.2024.108783_bib29","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3390\/cancers14246262","article-title":"A label-free proteomic approach for the identification of biomarkers in the exosome of endometrial cancer serum","volume":"14","author":"Sommella","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108783_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41388-020-01555-x","article-title":"Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression","volume":"40","author":"Song","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ejso.2024.108783_bib31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41416-022-02139-0","article-title":"Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women","volume":"128","author":"Njoku","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2024.108783_bib32","doi-asserted-by":"crossref","first-page":"S483","DOI":"10.33549\/physiolres.934375","article-title":"Differential urinary proteomic analysis of endometrial cancer","volume":"68","author":"Kac\u00edrov\u00e1","year":"2019","journal-title":"Physiol Res"},{"key":"10.1016\/j.ejso.2024.108783_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11259-018-9734-0","article-title":"Cervico-vaginal mucus (CVM)\u2013an accessible source of immunologically informative biomolecules","volume":"42","author":"Adnane","year":"2018","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.ejso.2024.108783_bib34","series-title":"Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using LC-MS\/MS","author":"Olagunju","year":"2021"},{"key":"10.1016\/j.ejso.2024.108783_bib35","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10632","article-title":"Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples","volume":"7","author":"Martinez-Garcia","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2024.108783_bib36","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/1933719112443879","article-title":"Uterine lavage or aspirate: which view of the intrauterine environment?","volume":"19","author":"Hannan","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejso.2024.108783_bib37","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.3390\/cancers13153804","article-title":"Comprehensive library generation for identification and quantification of endometrial cancer protein biomarkers in cervico-vaginal fluid","volume":"13","author":"Njoku","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108783_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105064","article-title":"Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery","volume":"102","author":"Njoku","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejso.2024.108783_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/cancers15030911","article-title":"Cervical fluids are a source of protein biomarkers for early, non-invasive endometrial cancer diagnosis","volume":"15","author":"Martinez-Garcia","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108783_bib40","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1158\/1078-0432.CCR-17-0474","article-title":"Targeted proteomics identifies proteomic signatures in liquid biopsies of the endometrium to diagnose endometrial cancer and assist in the prediction of the optimal surgical treatment","volume":"23","author":"Martinez-Garcia","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2024.108783_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202300055","article-title":"The tumour\u2010derived extracellular vesicle proteome varies by endometrial cancer histology and is confounded by an obesogenic environment","volume":"24","author":"Artuyants","year":"2024","journal-title":"Proteomics"},{"key":"10.1016\/j.ejso.2024.108783_bib42","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1210\/clinem\/dgab045","article-title":"Characterization and proteomic analysis of endometrial stromal cell\u2013derived small extracellular vesicles","volume":"106","author":"Hsu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2024.108783_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41588-024-01703-z","article-title":"Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response","volume":"56","author":"Hu","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejso.2024.108783_bib44","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3390\/cells11132119","article-title":"Tissue-based proteomic profiling in patients with hyperplasia and endometrial cancer","volume":"11","author":"Akkour","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejso.2024.108783_bib45","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbapap.2016.10.010","article-title":"Annexin A2 and alpha actinin 4 expression correlates with metastatic potential of primary endometrial cancer","volume":"1865","author":"Mittal","year":"2017","journal-title":"Biochim Biophys Acta BBA-Proteins Proteomics"},{"key":"10.1016\/j.ejso.2024.108783_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511987","article-title":"Phospho-DIGE identified phosphoproteins involved in pathways related to tumour growth in endometrial cancer","volume":"24","author":"Capaci","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2024.108783_bib47","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.3390\/ijms23147779","article-title":"Identification of candidate biomarker and drug targets for improving endometrial cancer racial disparities","volume":"23","author":"Javadian","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2024.108783_bib48","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22725","article-title":"A proteomic approach for the identification of biomarkers in endometrial cancer uterine aspirate","volume":"8","author":"Ura","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2024.108783_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.523989","article-title":"Proteomic analysis of pre-invasive serous lesions of the endometrium and fallopian tube reveals their metastatic potential","volume":"10","author":"Acland","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2024.108783_bib50","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1021\/acs.jproteome.0c00064","article-title":"SWATH-MS analysis of FFPE tissues identifies stathmin as a potential marker of endometrial cancer in patients exposed to tamoxifen","volume":"19","author":"Janacova","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ejso.2024.108783_bib51","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1074\/mcp.RA120.002012","article-title":"Kinome profiling of primary endometrial tumors using multiplexed inhibitor beads and mass spectrometry identifies SRPK1 as candidate therapeutic target","volume":"19","author":"Kurimchak","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ejso.2024.108783_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1051280","article-title":"Apolipoproteins: new players in cancers","volume":"13","author":"He","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejso.2024.108783_bib53","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1002\/cam4.2587","article-title":"Apolipoproteins and cancer","volume":"8","author":"Ren","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejso.2024.108783_bib54","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/cancers14071847","article-title":"MMP9: a tough target for targeted therapy for cancer","volume":"14","author":"Augoff","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108783_bib55","first-page":"5","article-title":"Annexin A2 and cancer: a systematic review","volume":"52","author":"Christensen","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejso.2024.108783_bib56","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.3390\/cancers13143639","article-title":"Two dimensional-difference in gel electrophoresis (2D-DIGE) proteomic approach for the identification of biomarkers in endometrial cancer serum","volume":"13","author":"Ura","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108783_bib57","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3390\/ijms23042076","article-title":"Gel-based proteomic identification of suprabasin as a potential new candidate biomarker in endometrial cancer","volume":"23","author":"Celsi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2024.108783_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324008515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324008515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:12:49Z","timestamp":1774858369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324008515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0748798324008515"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108783","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the protein signature of endometrial cancer: A comprehensive review through diverse samples and mass spectrometry-based proteomics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108783"}}